Science Corporation Raises $400M in Series D Financing at $3.5B Valuation to Advance Vision-Restoring Implants and Brain-Computer Interface Technology
1 day ago
1 min read
Updated: 8 hours ago
Alameda, CA, November 17, 2026 (Bloomberg) -- Science Corporation, a medical technology startup founded by former Neuralink president Max Hodak, has raised $400 million in a Series D financing round, bringing its reported valuation to $3.5 billion. Investors include Khosla Ventures, Ackman Oxman Institute, Tenet Healthcare, 885 Capital, Y Combinator, and PLC Neurotech. The financing will support the expansion and commercialization of the company's PRIMA retinal implant, a device designed to restore partial vision in patients with advanced age-related macular degeneration.
Read full article here.






















Comments